HIGHLIGHTS
- who: Linda Silina et al. from the Institut Curie, CNRS, UMR144, Equipe Labellisu00e9e Ligue Contre le Cancer, PSL Research University, Paris, France have published the research: Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation, in the Journal: (JOURNAL)
- what: The aim of the study was to improve these treatments by investigating novel approach where in addition to radiotherapy receptor member of receptor tyrosine kinase family known to be highly expressed on the bladder cancer cells and involved in the control of cell survival is targeted. The authors therefore sought to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.